Synthesis Of Gold Nanorods Using The Seed Mediated Method And Its Conjugation With Antibody For Diagnostics Applications by Teoh, Poay Ling
 
SYNTHESIS OF GOLD NANORODS USING THE SEED MEDIATED 
METHOD AND ITS CONJUGATION WITH ANTIBODY FOR 
DIAGNOSTIC APPLICATIONS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TEOH POAY LING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
 
2012
SYNTHESIS OF GOLD NANORODS USING THE SEED MEDIATED METHOD 
AND ITS CONJUGATION WITH ANTIBODY 
FOR DIAGNOSTIC APPLICATIONS  
 
 
 
 
 
 
 
 
 
 
by 
 
 
 
 
 
 
 
 
 
 
TEOH POAY LING 
 
 
 
 
 
 
 
 
 
Thesis submitted in fulfillment of the requirements  
for the degree of 
Master of Science 
 
 
 
 
 
 
 
 
 
February 2012 
ii 
 
DECLARATION 
 
 
 
          I hereby declare that I have conducted, completed the research work and written 
the dissertation entitled “Synthesis of gold nanorods using the seed mediated method 
and its conjugation with antibody for diagnostic application”. I also declare that it has 
not been previously submitted for the award of any degree or diploma or other similar 
title of this for any other examining body or University.  
 
Name of Student: Teoh Poay Ling                                         Signature:  
                    Date:  
 
Witness by  
         Supervisor: Dr. Khairunisak Abdul Razak                     Signature:  
                   Date: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
ACKNOWLEDGEMENTS 
 
 
 
 
First of all, I would like to express my sincere gratitude to my supervisor, Dr. 
Khairunisak Abdul Razak for her guidance, assistance and her patience in this research. I 
am impressed by her beautiful sharp mind. I also would like to express my honour 
gratitude to Assoc. Prof. Dr. Shaharum Shamsuddin and Assoc. Prof. Dr. Azlan Abdul 
Aziz for their guidance and help.  
 
I would like to thank all technicians in School of Materials and Mineral 
Resources Engineering and INFORMM who helped me a lot especially Ms. Diana, 
Madam Fong and Mr. Mohd. Azrul. Besides, I would like to express my appreciation to 
my best friends Mr. Navan, Ms. Rabizah, Ms. Hajarul, Ms. Shimah, Ms. Syafinaz, Ms. 
Ng Soo Ai, Ms. Ng Chai Yan for sharing my laughs and tears. Befriends with all of you 
is the most beautiful parts of my life at School of Materials and Mineral Resources 
Engineering and INFORMM. Also I would like to thank Universiti Sains Malaysia for 
awarding me with USM Fellowship, which covers my living expenses and tuition fees 
during two years of research. Finally, I would like to express my deepest gratitude to my 
family for providing constant moral support and encouragement.  
 
Thank you. 
 
 
 
iv 
 
TABLE OF CONTENTS 
 Page 
TITLE i 
DECLARATION ii 
ACKNOWLEDGEMENTS 
 
iii 
TABLE OF CONTENTS 
 
iv 
LIST OF TABLES 
 
viii 
LIST OF FIGURES 
 
x 
LIST OF ABBREVIATIONS 
 
xviii 
LIST OF SYMBOLS xx 
ABSTRAK xxi 
ABSTRACT xxii 
  
CHAPTER 1: INTRODUCTION 
 
 
1.1 Research background 1 
1.2        Problem statement 4 
1.3        Objectives 6 
1.4        Overview of thesis 6 
   
CHAPTER 2: LITERATURE REVIEW 
 
 
2.1 Introduction 8 
2.2 Brief history of gold nanoparticles (AuNPs) 8 
2.3 Definition and background studies of gold nanoparticles (AuNPs) 9 
2.4 Optical properties: Surface plasmon resonance (SPR) in gold            
nanoparticles (AuNPs) 
16
2.5 Synthesis methods to produce gold nanoparticles (AuNPs) 22 
 2.5.1 Gold nanospheres (AuNSs) 23 
 2.5.2 Gold nanorods (AuNRs) 36 
v 
 
      2.5.2.1 Synthesis parameters 40 
                  (a) Effect of surfactant 40 
                  (b) Effect of silver 46 
                  (c) Effect of synthesis temperature 49 
2.6         Shape separation of colloidal gold nanorods (AuNRs) 52 
2.7          Stability of colloidal gold 55 
 2.7.1   Critical coagulation concentration (CCC) 56 
 2.7.2    Electrostatic stabilization 58 
 2.7.3    Polymeric stabilization 59 
2.8 Antibodies 61 
2.9 Bioconjugation strategies   67 
2.10        Applications of gold nanoparticles (AuNPs)  74 
 2.10.1   Diagnostic applications 74 
              (i) Biosensor application 75 
              (ii) Imaging application   80 
 2.10.2   Therapeutics applications 82 
              (i) Photothermal therapy 82 
              (ii) Drug delivery system 85 
   
CHAPTER 3: METHODOLOGY 
 
 
3.1         Introduction 87 
3.2         Experimental Procedures  88 
 3.2.1    Synthesis of gold nanoparticles (AuNPs) using stepwise citrate  
            seed mediated growth method 
88 
  3.2.2   Synthesis of gold nanoparticles (AuNPs) using CTAB capped   
            seed mediated growth method 
91 
             3.2.2 (a)   Preparation of seed solution 91 
             3.2.2 (b)   Preparation of growth solution 91 
3.3         Gold nanorods (AuNRs) PEGylation 93 
3.4         Preparation of SH groups containing mouse anti-human IgG4 (DL- 94 
vi 
 
dithiothreitol (DTT) reduction method) 
3.5 Optimization for production of reduced mouse anti-human IgG4 95 
 3.5.1   Sodium dodecyl sulphate-polyacrylamide gel electrophoresis  
           (SDS PAGE)  
95 
 3.5.2   Silver staining of SDS-PAGE gel 97 
 3.5.3   Molecular weight estimation of reduced mouse anti-human IgG4    
                 using SDS-PAGE 
98 
3.6         Direct conjugation of gold nanorods (AuNRs) to mouse anti-human IgG4 
and reduced mouse anti-human IgG4 
99 
3.7 Covalent attachment between gold naorods (AuNRs) with reduced 
mouse anti-human IgG4  
100 
3.8 Characterization for conjugation of AuNRs with mouse anti-human IgG4  102 
 3.8.1   ICG strip assay or lateral-flow assay procedure 102 
3.9 Samples characterization  104 
 3.9.1    Transmission electron microscopy (TEM) analysis 105 
 3.9.2    Ultraviolet-Visible near-infrared spectrophotometer (UV-Visible        
            NIR spectrophotometer) 
105 
 3.9.3    X-ray powder diffraction (XRD) 106 
   
CHAPTER 4: RESULTS AND DISCUSSION  
 
 
4.1         Introduction 107 
4.2         Citrate seed mediated growth method 108 
 4.2.1 Effect of silver nitrate (AgNO3) concentration 111 
 4.2.2 Effect of CTAB concentration 118 
 4.2.3 Effect of volume of seed solution 123 
4.3          CTAB seed mediated growth method 126 
 4.3.1 Effect of CTAB concentration 128 
vii 
 
 4.3.2 Effect of volume of seed solution 137 
 4.3.3 Effect of ascorbic acid concentration 145 
 4.3.4 Effect of nitric acid volume 153 
4.4         Stability of the AuNRs 163 
4.5         Conjugation of gold nanorods (AuNRs) with mouse anti-human IgG4 165 
 4.5.1 Gold nanorods (AuNRs) PEGylation 168 
 4.5.2 SMCC-Based conjugation 170 
 4.5.3 Molecular weight estimation of reduced mouse anti-human IgG4    
         by using sodium dodecyl sulphate-polyacrylamide gel    
        electrophoresis (SDS-PAGE) analysis 
171 
 4.5.4 Development and optimization of the immunochromatrographic   
         (ICG) strip assay 
174 
         (a) Mouse anti-human IgG4 conjugated to AuNRs 174 
         (b) Reduced mouse anti-human IgG4 conjugated to AuNRs 179 
         (c) Reduced mouse anti-human IgG4 covalently conjugated to  
             AuNRs using a SMCC crosslinker 
182 
 4.5.5  Determination of test results with positive and negative serum 184 
   
   
CHAPTER 5: CONCLUSIONS AND RECOMMENDATION 
 
 
5.1         Conclusions 187 
5.2         Recommendation for future work 188 
   
REFERENCES 
APPENDICES 
190 
 
 
 
viii 
 
LIST OF TABLES 
                                                                                                                                      Page 
Table 2.1:    Methods to synthesize AuNPs       
                                                            
13 
Table 2.2:    Size and shape determine the physical colour of AuNPs    
                       
19 
Table 2.3:     Plasmon mode of the AuNPs with varying shapes    
                                
21 
Table 2.4:     Reducing agents in synthesizing AuNSs       
                                            
24 
Table 2.5:     Particles size, plasmon band maximum and size distribution  
synthesized with stepwise and one step of seeding growth method  
          
34 
Table 2.6:     Methods to produce AuNRs      
                                                                 
40 
Table 2.7:     List of growth reaction using different supplier CTAB      
                         
42 
Table 2.8:     Summary of AuNRs with synthesis temperature       
                                 
50 
Table 2.9:     The size of mother sol and after sample centrifugation            
                  
54 
Table 2.10:   The crosslinker reagents for coupling protein to nanoparticles      
              
68 
Table 2.11:   Reported LOD and assay time for gold labeling in  
immunochromatographic strip assay        
                                                    
78 
Table 3.1:    The amount of all parameters to synthesize AuNPs         
                             
90 
Table 3.2:    Summary of the effect of parameter study                
                                     
93 
Table 4.1: Dimension of gold nanorods (AuNRs) and bipyramids (BPs) at 
Step B 
 
116 
Table 4.2: Aspect ratio of gold nanorods (AuNRs) and bipyramids (BPs) 
 
122 
Table 4.3: Physical properties of AuNRs with varying CTAB concentration; 
transverse surface plasmon (TSP), longitudinal surface plasmon 
(LSP) position, length, diameter and aspect ratio 
 
133 
Table 4.4: Physical properties of AuNRs with varying volume of seed 
solution; transverse surface plasmon (TSP), longitudinal surface 
plasmon (LSP) position, length, diameter and aspect ratio 
 
142 
  
 
 
ix 
 
Table 4.5: Physical properties of AuNRs with varying ascorbic acid 
concentration; transverse surface plasmon (TSP), longitudinal 
surface plasmon (LSP) position, length, diameter and aspect ratio 
 
150 
Table 4.6: Physical properties of AuNRs with varying volume of nitric acid; 
transverse surface plasmon (TSP), longitudinal surface plasmon 
(LSP) position, length, diameter and aspect ratio 
 
160 
Table 4.7: Physical properties of AuNRs PEGylation with varying volume of 
PEG-amine; transverse surface plasmon (TSP), longitudinal 
surface plasmon (LSP) position 
 
170 
Table 4.8: The distinct fragments of  mouse anti-human IgG4 antibody after 
reducing by DTT 
 
173 
Table 4.9: Values of absorbance and plasmon locations of AuNRs and 
AuNRs directly conjugated to  mouse anti-human IgG4 
 
177 
Table 4.10: Values of absorbance and plasmon locations of AuNRs and 
AuNRs directly conjugated to reduced  mouse anti-human IgG4 
 
180 
Table 4.11: Values of absorbance and plasmon locations of AuNRs and 
AuNRs covalently conjugated to reduced  mouse anti-human IgG4 
 
 
183 
  
 
 
 
 
 
 
 
 
 
 
x 
 
LIST OF FIGURES 
                                                                                                                                        
Figure 2.1: SPR occurs when the interaction between electromagnetic (EM)  
field with the electrons in the conduction band for a metal 
sphere 
 
17 
Figure 2.2:  Optical absorption spectra of AuNRs with different aspect 
ratios:  
(a) 2.4; (b) 3.0; (c) 3.9; (d) 4.8; (e) 5.6              
 
18 
Figure 2.3:  Photograph of five of AuNRs solution. Aspect ratios are  
(a) 1.7, (b) 2.3, (c) 2.7, (d) 3.5 and (e) 4.0 (from the left to right)   
          
20 
Figure 2.4: The color of AuNRs solution of having different amount of  
spheres as byproduct. (a) 50%, (b) 30%, (c) 10%, and (d) 0%   
                  
20 
Figure 2.5: Schematic illustration of plasmon resonance of solid metal,  
(A) gold nanoparticle, (B) nanorod, (C) hollow gold 
nanospheres (HGN), and (D) aggregate gold nanoparticles         
 
22 
Figure 2.6: Transmission electron microscopy images of Na3Ct/HAuCl4 
molar ratio from 0.7:1 to 17.5:1 ((a)-(e)), (f) average size AuNPs 
synthesis with different Na3Ct/HAuCl4 molar ratio              
 
27 
Figure 2.7: Predictions of dependence of particle size on the ratio of citric 
acids to gold for fixed value of [T0] = 3 X 10
-4
 M 
 
29 
Figure 2.8: Mechanism of growth and agglomeration of AuNSs synthesized 
with varying pH, (a) pH < 5.0, (b) 5.9 < pH < 7.2, and (c) 
pH > 9.1 
 
30 
Figure 2.9: Transmission electron micrographs of AuNPs obtained by 
citrate reduction at the different pH values      
     
31 
Figure 2.10: TEM images of AuNSs grown with seeding growth method:  
(a) 50 nm, (b) 78 nm, (c) 105 nm, and (d) 143 nm      
 
34 
Figure 2.11: An AuNRs created by CTAB bilayer. The black circles 
represent ammonium head groups while the yellow zig zag 
represents hydrocarbon tail of CTAB         
 
41 
Figure 2.12: TEM (top images labeled with “1”) and SEM (bottom images 
labeled with “2”) images of AuNPs with CTAB from five 
different suppliers: (A) Fluka (52370) (B) MP Biomedicals (C) 
Acros (D) Sigma (H5882) and (E) Aldrich. Only CTAB supplied 
43 
xi 
 
by Fluka and MP Biomedicals yielded nanorods, while the 
others yielded only spherical particles      
 
Figure 2.13: TEM micrographs of AuNPs prepared in the presence of  
(a) C10TAB, (b) C12TAB, (c) C14TAB, and (d)C16TAB     
     
44 
Figure 2.14: XRD pattern of AuNRs prepared using seed mediated growth 
method 
 
45 
Figure 2.15: Influence of the type of surfactant used in growth solution on the 
morphology of the AuNRs:, (a) CTAB, (b) CTAC and  
(c) CTAB + BDAC. The scale bar is 50 nm         
           
46 
Figure 2.16: An underpotential deposition (UPD) of silver atom on Au {111}, 
{100}, and {110} facets         
       
47 
Figure 2.17: (a) High-Resolution TEM image of citrate seeds and (b) TEM 
image of gold nanostructures grown from citrate seeds with 
silver      
 
49 
Figure 2.18: (a) High-Resolution TEM image of CTAB seed and (b) TEM 
image of AuNRs grown from CTAB seeds with silver        
            
49 
Figure 2.19: TEM images of nine samples prepared at: (a) 2.5°C, (b) 10°C,  
(c) 15°C, (d) 20°C (e) 25°C, (f) 55°C, (g) 80°C and (h) 95°C. 
The scale bar is 500 nm for images a-d, 100 nm for images e, g 
and h, and 50 nm for image f       
 
50 
Figure 2.20: Evolution of the integrated absorbance vs time for AuNRs 
synthesized at different temperatures      
 
52 
Figure 2.21: UV-Vis-NIR spectrum of (a) mother colloidal sol and (b) 
separated sols deposited on the side wall and deposit at the 
bottom of tube     
 
53 
Figure 2.22: Figure 2.22: TEM images of AuNRs: (a) before centrifuge, (b) 
after centrifuge-nanorods deposited at the side of the centrifuge 
tube and (c) after centrifuge-sediment deposited at the bottom of 
the centrifuge tube  
53 
Figure 2.23: UV-Vis-NIR spectra for the CTAB series at (a) 100 mM, (b) 
1mM and (c) 0.5 mM      
 
55 
Figure 2.24: Time resolved absorption spectra of AuNRs in the presence of 
NaCl with a certain concentration of (a) 0.86 M and (b) 2.58 M  
      
57 
Figure 2.25: Effect of polymer chains on the colloidal dispersion     
 
60 
xii 
 
Figure 2.26: Structure of antibody       
 
62 
Figure 2.27: 
 
Separation of IgG antibodies into fragments using SDS-PAGE, 
(a) lane 1-4: IgG treated with DTT, lane 5-8: different amount 
IgG without DTT, (b) different amount of IgG reduced by DTT  
     
66 
Figure 2.28: SDS-PAGE results of anti-CEA antibody reduction using TCEP 
(reducing agent) concentration of 0x, 3x, 10x and 30x over the 
concentration of the antibody       
 
67 
Figure 2.29: EDC reacts with carboxylic acids to create an active-ester 
intermediate. In the presence of an amine nucleophile, an amide 
bond is formed with release of an isourea by-product       
  
70 
Figure 2.30: Maleimide coupling of an amine (NH2) group and thiol (SH) 
group using SMCC as a linker      
 
73 
Figure 2.31: Classification of the diagnostic applications of AuNPs    
 
75 
Figure 2.32: Immunochromatographic strip test device       
  
78 
Figure 2.33: Diagnostic tool for meningococcal diagnostic test     
  
80 
Figure 2.34: Various applications of gold nanoparticles (AuNPs) in therapy 
application                
 
82 
Figure 2.35: Synthesis of MMP-AuNR for simultaneous imaging and 
photothermal therapy             
       
84 
Figure 3.1: Flow chart of the AuNPs synthesis route       
       
89 
Figure 3.2: The Amicon Ultra-0.5 product includes 5 different cutoffs      
      
95 
Figure 3.3: Broad range protein molecular weight markers   
        
98 
Figure 3.4: The structure of SMCC   
            
101 
Figure 3.5: Schematic diagram of ICG strip assay 
 
102 
Figure 3.6: Schematic diagram of analyzing ICG strip assay performance 
after tested with serum. C = control line, T = test line 
104 
   
Figure 4.1: Representation of citrate seed mediated growth for AuNPs 
 
110 
Figure 4.2: (a) TEM images of the citrate seeds grown in aqueous solution 
and (b) UV-Vis spectra of citrate seeds. 
 
111 
xiii 
 
Figure 4.3: UV-Vis-NIR spectra of gold products synthesized by varying 
AgNO3 concentration. CTAB concentration and seed solution 
were fixed to 0.2 M and 2 ml, (a) Step A, (b) Step B, and (c) 
Step C 
 
113 
Figure 4.4: TEM images of gold products synthesized under Step B 
condition by varying AgNO3 concentration. CTAB concentration 
and seed solution fixed at 0.2 M and 2 ml respectively: (a) 0.004 
M AgNO3, (b) 0.007 M AgNO3, (c) 0.010 M AgNO3, and (d) 
0.015 M AgNO3 
 
115 
Figure 4.5: TEM images of gold products synthesized under Step C 
condition with CTAB concentration and seed solution fixed to 
0.2 M and 2 ml, respectively: (a) 0.007 M AgNO3, and (b) 0.015 
M AgNO3 
 
116 
Figure 4.6: Shaped evolution for synthesizing of the AuNPs under desired 
silver nitrate concentration at Step B and Step C with CTAB 
concentration and seed solution were fixed to 0.2 M and 2 ml 
respectively 
 
117 
Figure 4.7: UV-Vis-NIR spectra of gold products synthesized with varying 
CTAB concentration by fixing the AgNO3 concentration at 0.004 
M and 2 ml seed solution at:  (a) Step A, and (b) Step B 
 
119 
Figure 4.8: TEM images of gold products synthesized under Step B 
condition with varying CTAB concentration by fixing the 
AgNO3 concentration at 0.004 M and 2 ml seed solution was 
used, (a) 0.1 M, (b) 0.2 M and (c) 0.3 M 
 
121 
Figure 4.9: Shapes evolution for synthesizing of the AuNPs under desired 
CTAB concentration at Step B by fixing the AgNO3 
concentration at 0.004 M and 2 ml seed solution was used 
 
 
122 
Figure 4.10: UV-Vis-NIR spectra of gold products synthesized with varying 
volume of seed solution by fixing the AgNO3 concentration at 
0.004 M and CTAB concentration at 0.2 M at: (a) Step A, and 
(b) Step B 
 
123 
Figure 4.11: TEM images of gold products synthesized under Step B 
condition with varying volume of seed solution by fixing the 
AgNO3 concentration at 0.004 M and CTAB concentration at 
0.2 M, (a) 1.1 ml, (b) 1.5 ml, (c) 2.0 ml, and (d) 2.5 ml 
 
125 
 
Figure 4.12: 
 
Shaped evolution for synthesizing AuNPs under desired volume 
 
126 
xiv 
 
of seed solution at Step B by fixing the AgNO3 concentration at 
0.004 M and 0.2 M CTAB 
 
Figure 4.13: Photography of CTAB seed prepared in deionized water after 2 
hours 
 
127 
Figure 4.14: (a) TEM images of the CTAB seeds grown in aqueous solution 
and (b) particles size distributions of CTAB seeds 
 
128 
Figure 4.15: UV-Vis-NIR spectra of the AuNRs solution with varying CTAB 
concentration 
 
129 
Figure 4.16: TEM images of the AuNRs with varying CTAB concentrations; 
(a) 0.10 M, (b) 0.15 M, (c) 0.20 M, and (d) 0.30 M 
 
131 
Figure 4.17: Histograms for distribution of diameter of AuNRs: (a) 0.10 M, 
(b) 0.15 M, (c) 0.20 M, and (d) 0.30 M CTAB and length of 
AuNRs: (e) 0.10 M, (f) 0.15 M, (g) 0.20 M, and (h) 0.30 M 
CTAB. 
 
132 
Figure 4.18: The trend of (a) transverse and longitudinal surface plasmon of 
AuNRs, (a) length and diameter of AuNRs and (c) aspect ratio 
of AuNRs with varying CTAB concentration 
 
135 
Figure 4.19: XRD patterns of AuNRs with effect of CTAB concentration; 
(a) 0.10 M, (b) 0.15 M, (c) 0.20 M, and (d) 0.30 M 
 
137 
Figure 4.20: UV-Vis-NIR spectra of the AuNRs s solution with varying 10 μl 
until 70 μl seed solution 
 
138 
Figure 4.21: TEM images of the AuNRs at various volume of seed solution 
(a) 10 μl, (b) 30 μl, (c) 50 μl, and (d) 70 μl 
 
140 
Figure 4.22: Histograms for distribution of diameter of AuNRs: (a) 10 μl,  
(b) 30 μl, (c) 50 μl, and (d) 70 μl seed solution and length of 
AuNRs: (e) 10 μl, (f) 30 μl, (g) 50 μl, and (h) 70 μl seed 
solution. 
 
141 
Figure 4.23: The trend of (a) transverse and longitudinal surface plasmon of 
AuNRs, (b) length and diameter of AuNRs and (c) aspect ratio 
of AuNRs with volume of seed solution 
 
143 
Figure 4.24: XRD patterns of AuNRs with effect of volume of seed solution 
by fixing the CTAB concentration to 0.20 M and ascorbic acid 
concentration of 0.08 M; (a)10 µl, (b) 30 µl, (c) 50 µl, and 
(d) 70 µl 
 
145 
xv 
 
Figure 4.25: UV-Vis-NIR spectra of the AuNRs solution with the addition of 
0.07 M until 0.10 M ascorbic acid (AA) with CTAB 
concentration was fixed to 0.20 M and 50 µl seed solution was 
used 
 
147 
Figure 4.26: TEM images of the AuNRs at various ascorbic acid 
concentrations at (a) 0.07 M, (b) 0.08 M, (c) 0.09 M, and 
(d) 0.10 M 
 
148 
Figure 4.27: Histograms for distribution of diameter of AuNRs: (a) 0.07 M, 
(b) 0.08 M, (c) 0.09 M, and (d) 0.10 M ascorbic acid and length 
of AuNRs: (e) 0.07 M, (f) 0.08 M, (g) 0.09 M, and (h) 0.10 M 
ascorbic acid. 
 
149 
Figure 4.28: The trend of (a) transverse and longitudinal surface plasmon of 
AuNRs, (b) length and diameter of AuNRs and (c) aspect ratio 
of AuNRs with varying ascorbic acid concentration 
 
151 
Figure 4.29: XRD patterns of AuNRs with effect of ascorbic acid 
concentrations with CTAB concentration were fixed to 0.20 M 
and 50 µl seed solution were used; (a) 0.07 M, (b) 0.08 M, 
(c) 0.09 M, and (d) 0.10 M 
 
153 
Figure 4.30: UV-Vis-NIR spectra of the AuNRs solution with varying volume 
of HNO3 with CTAB concentration was fixed to 0.20 M, 50 µl 
seed solution was used and ascorbic acid was fixed to 0.08 M 
 
155 
Figure 4.31: TEM images of AuNRs synthesized using different volume of 
HNO3 with CTAB concentration was fixed to 0.20 M, 50 µl seed 
solution was used and ascorbic acid was fixed to 0.08 M; 
(a) 0 µl, (b) 100 µl, (c) 200 µl, (d) 300 µl, (e) 400 µl, and 
(f) 600 µl 
 
156 
Figure 4.32: Histograms for distribution of diameter of AuNRs: (a) 100 µl, 
(b) 200 µl, (c) 300 µl, (d) 400 µl, and (e) 600 µl nitric acid and 
length of AuNRs: (f) 100 µl, (g) 200 µl, (h) 300 µl, (i) 400 µl, 
and (j) 600 µl nitric acid. 
 
158 
Figure 4.33: The trend of (a) transverse and longitudinal surface plasmon of 
AuNRs, (b) length and diameter of AuNRs and (c) aspect ratio 
of AuNRs with volume of HNO3 
 
161 
Figure 4.34: UV-Vis-NIR spectra of the solution with varying volume of 
HNO3 and without AgNO3 
 
 
162 
Figure 4.35: Mechanism of AuNRs growth from CTAB gold seed 163 
xvi 
 
nanoparticles in the presence HNO3 or AgNO3 
 
Figure 4.36: Photographs of colloidal AuNRs. Storage duration is (a) 1 day, 
(b) 1 week and (c) 4 weeks at room temperature 
 
164 
Figure 4.37: UV-Vis-NIR spectra of the AuNRs solution which after 1 day 
and 4 weeks 
 
164 
Figure 4.38: Bioconjugation reaction of AuNRs-amine to free sulhydryl-
containing mouse anti-human IgG4 
 
166 
Figure 4.39: Schematic representation of the gold nanorods (AuNRs) 
PEGylation 
 
169 
Figure 4.40: UV-Vis-NIR spectra of the AuNRs solution with varying volume 
of PEG-amine 
 
169 
Figure 4.41: Solutions of conjugation of AuNRs with SMCC. From left to 
right the SMCC concentration are 0.1 mM, 0.5 mM, 1mM, 2 
mM, 4 mM and 5 mM 
 
171 
Figure 4.42: Separation of mouse anti-human IgG4 into fragments using SDS-
PAGE analysis. All samples were loaded with 20 μg of mouse 
anti-human IgG4. Lane 1-7 is IgG4 heated at 93˚C prior SDS-
PAGE, but different DTT concentration to reduce mouse anti-
human IgG4. From lane 1 to 7 the DTT concentrations are 1 
mM, 5 mM, 10 mM, 20 mM, 100 mM, 200 mM and 400 mM, 
respectively. From lane 8-10, mouse anti-human IgG4 was 
treated with 400 mM DTT and heated at 37˚C prior SDS-PAGE 
at 20 mins, 40 mins and 60 mins 
 
173 
Figure 4.43: ICG strip assay using AuNRs directly conjugated to mouse anti-
human IgG4. From left to right are HF 90, HF 135 and HF 240 
membrane 
 
175 
Figure 4.44: The colloidal AuNRs were challenged with NaCl. Tube 1: 2 
μg/ml mouse anti-human IgG4, Tube 2: 4 μg/ml mouse anti-
human IgG4, Tube 3: 5 μg/ml mouse anti-human IgG4, Tube 4: 6 
μg/ml mouse anti-human IgG4, Tube 5: 8 μg/ml mouse anti-
human IgG4, Tube 6: 10 μg/ml mouse anti-human IgG4, Tube 7: 
20 μg/ml mouse anti-human IgG4, Tube C1: 1 ml of AuNRs, and 
Tube C2: 0.5 ml AuNRs + 0.5 ml NaCl 
 
176 
Figure 4.45: UV-Vis-NIR spectra of AuNRs and AuNRs directly conjugated 
to mouse anti-human IgG4 
 
 
177 
xvii 
 
Figure 4.46: ICG strip assay using AuNRs directly conjugated to mouse anti-
human IgG4. From left to right the concentration of mouse anti-
human IgG4 are 2, 4, 6, and 8 μg/ml 
 
179 
Figure 4.47: UV-Vis-NIR spectra of AuNRs and AuNRs directly conjugated 
to reduced mouse anti-human IgG4 
 
180 
Figure 4.48: ICG strip assay using AuNRs directly conjugated to reduced-
IgG4. From left to right the amount of reduced mouse anti-
human IgG4 are 2, 4, 6, 8 and 10 μl 
 
181 
Figure 4.49: UV-Vis-NIR spectra of AuNRs and AuNRs covalently 
conjugated to reduced mouse anti-human IgG4 
 
182 
Figure 4.50: ICG strip assay using AuNRs covalently conjugated to reduced 
mouse anti-human IgG4. From left to right the amount of 
reduced mouse anti-human IgG4 are 5, 10, 15, 20 and 25 μl 
 
184 
Figure 4.51: ICG strip assay (a) to (c) is test with positive serum result, while 
test strip (d) to (e) is test with negative serum result. 
(a) & (d): mouse anti-human IgG4 directly conjugated to 
AuNRs, 
(b) & (e): reduced mouse anti-human IgG4 conjugated to AuNRs 
and 
(c) & (f): mouse anti-human IgG4 covalently conjugated to 
AuNRs using a SMCC crosslinker. 
 
186 
 
 
 
 
 
 
 
 
 
 
xviii 
 
LIST OF ABBREVIATIONS 
 
Abbreviations Compound 
AgNO3 Silver nitrate 
Au Gold 
AuNPs Gold nanoparticles 
AuNSs Gold nanospheres 
AuNRs Gold nanorods 
BSA Bovine serum albumin 
CTAB Cetyltrimenthylammonium bromide 
DI deionized 
DTT Dithiothreitol  
HAuCl4 Gold chloride   
HNO3 Nitric acid 
ICG Immunochromatographic 
IgG Immunoglobulin G 
LSP Longitudinal surface plasmon  
NaBH4 sodium borohydride 
Na3Ct Trisodium citrate 
NIR Near-infrared 
PEG Polyethylene glycol 
SMCC succinimidyl-4-(N-maleimidomethyl)cyclohexana-1-
carboxylate  
 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis 
xix 
 
 
SPR Surface plasmon resonance 
TEM Transmission electron microscopy 
TSP Transverse surface plasmon  
 UV-Visible NIR    Ultraviolet-Visible near-infrared 
 XRD X-ray powder diffraction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xx 
 
LIST OF SYMBOLS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
nm Nanometer 
λ Wavelength 
˚C Degree celcius 
L Length 
D Diameter 
M Molar 
Da Dalton 
xxi 
 
SINTESIS NANORODS EMAS MENGGUNAKAN KAEDAH PERANTARA 
PEMBENIHAN DAN KONJUGAT DENGAN ANTIBODI UNTUK KEGUNAAN 
DIAGNOSTIK 
 
ABSTRAK 
 
           Penyelidikan ini melibatkan sintesis nanorod emas (AuNRs) dengan kaedah 
perantara pembenihan sitrat dan perantara pembenihan bromida 
cetyltrimethylammonium (CTAB). AuNRs terkonjugat antibodi adalah untuk kegunaan 
diagnostik. AuNRs disintesis oleh kaedah perantara pembenihan sitrat melibatkan dua 
peringkat: pernyediaan larutan benih dan peringkat pertumbuhan. Perbandingan dari segi 
hasil AuNRs daripada kedua-dua jenis larutan benih, didapati AuNRs yang lebih banyak 
dan lebih panjang dihasilkan menggunakan benih dari pembenihan CTAB. Sementara itu, 
ciri-ciri AuNRs juga dipengaruhi oleh parameter sintesis daripada larutan pertumbuhan 
seperti kepekatan argentum nitrat (AgNO3), kepekatan CTAB, kepekatan asid askorbik, 
isipadu larutan benih dan isipadu asid nitrik (HNO3). Di antara sampel ini, parameter 
sintesis yang optimum untuk menghasilkan AuNRs ialah 0.2 M CTAB, 0.08 M asid 
askorbik, 50µl larutan benih dan 300µl HNO3 melalui kaedah perantara benih CTAB. 
Parameter sintesis yang optimum menghasilkan 4.9 nisbah aspek AuNRs. Prestasi 
AuNRs terkonjugat mouse anti-human IgG4 telah berjaya diuji dengan menggunakan 
immunokromatografi jalur ujian. Daripada hasil jalur ujian, keamatan garis kawalan 
bertambah dengan pertambahan jumlah mouse anti-human IgG4. Keputusan ujikaji 
menunjukkan ikatan kovalen konjugat AuNRs dengan mouse anti-human IgG4 
menunjukkan konjugatan yang terbaik. 
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SYNTHESIS OF GOLD NANORODS USING THE SEED MEDIATED METHOD 
AND ITS CONJUGATION WITH ANTIBODY  
FOR DIAGNOSTIC APPLICATIONS  
 
ABSTRACT 
 
This work describes the synthesis of gold nanorods (AuNRs) produced using the 
citrate seed mediated method and cetyltrimethylammonium bromide (CTAB) seed 
mediated method. The AuNRs are conjugated with antibody for diagnostic applications. 
The synthesis of AuNRs via the seed mediated method involves two consecutive stages: 
preparation of seed solution and growth stage. The AuNRs were formed upon the 
addition of seed solution into the growth solution. By comparing the yield of AuNRs 
synthesized from both type of seed solutions, it was found that higher yield and longer 
AuNRs was produced by using CTAB seed solution. Meanwhile, the properties of 
AuNRs were also influenced by the synthesis parameters of the growth solution such as 
concentration of silver nitrate (AgNO3), concentration of CTAB, concentration of 
ascorbic acid, volume of seed solution and volume of nitric acid (HNO3). Among these 
samples, the optimum synthesis parameters to produce AuNRs were 0.2 M CTAB, 0.08 
M ascorbic acid, 50 l seed solution and 300 μl HNO3 via CTAB seed mediated growth 
method. The optimum synthesis parameters produced 4.9 aspect ratio of AuNRs. The 
performance of AuNRs conjugated mouse anti-human IgG4 was successfully checked 
using an immunochromatographic (ICG) strip assay. From the test strip result, the 
intensity of the control line increased with increasing the amount of mouse anti-human 
IgG4. The result showed that the covalent attachment between AuNRs and mouse anti-
human IgG4 exhibited the best conjugation. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1     Research background 
Nanotechnology based approaches have been broadly used in diagnostic 
applications owing to their high sensitivity, specificity, and abilities. Nanoparticles 
are recognized as the most common because of its small size in the range of 1-100 
nm, which has high surface-to-volume ratio, large surface area, unique electronic and 
optical properties (Hutchison, 2001; Burda et al., 2005; Jongnam et al., 2007). With 
the above characteristics, nanoparticles have been widely used in drug delivery 
system, cellular imaging and biomedical diagnostic, therapeutic, electrical, biosensor, 
magnetic, and medical fields (Liu et al., 2003; Yu et al., 2006; Otsuka et al., 2003; 
Sánchez-Sánchez et al., 2010). The well-studied nanoparticles including nanospheres, 
nanoshells, nanocages, nanorods, gold nanoparticles, quantum dots, paramagnetic 
nanoparticles, and carbon nanotubes, (Derfus et al., 2007; Gao et al., 2009; Kam et 
al., 2005; Hirsch et al., 2003b; Liao and Hafner, 2005; Skrabalak et al., 2007; Liu et 
al., 2007; Sun et al., 2008; Zhang et al., 2001). There are various methods to 
synthesize nanoparticles such as photochemistry, radiolysis, reverse micelles, arc 
discharge, seed-mediated growth, phase transfer reactions, direct reduction method 
etc (Shon et al., 2008; Waere et al. 2000; Brust et al., 1994;  Liu, 2004;  Jana et al., 
2001b; Tang et al., 1998).      
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Of major interest, gold nanoparticles (AuNPs) have gained wide attention in 
human science. The application of AuNPs has brought the passion of researchers in 
the information age. AuNPs exhibit excellent optical properties, good physical and 
chemical properties, chemically stable and nontoxic (Qiao et al., 2008; Kim et al., 
2001; Kumar et al., 2008; Daniel and Astruc, 2004; Zhang et al., 2001). AuNPs have 
been used in biomedical imaging, diagnostic tests applications, biochemical sensors, 
and therapeutics (Robert et al., 2006; Jesus et al., 2006; Marion et al., 2006; 
Chithrani et al., 2006; Hutter et al., 2010). The unique physical and chemical 
properties of AuNPs such as large surface area, availability of versatile chemistry for 
functionalizing AuNPs surface, and good bio-compaibility of AuNPs make them 
suitable for conjugation with biological molecules (Zhang et al., 2001; Li and 
Rothberg, 2004; Khalavka et al., 2009; Yang et al., 2009). Besides, AuNPs can be 
conjugated with bovine serum albumin (BSA) (Housni et al., 2008), peptides (Sun et 
al., 2008), deoxyribonucleic acid (DNA) (Claridge et al., 2008), polyvalent nucleic 
acid (Massich et al., 2009), dextran (Aveyard et al., 2008) and antibodies (Liu et al., 
2009; Pasqua et al., 2009; Eck et al., 2008; Zhang et al., 2001; Qiao et al., 2008; 
Kumar et al., 2008). Bioconjugation of AuNPs with various biological receptors 
provides wide range of applications in diagnostic, assembly, biosensor, biodetection, 
and imaging (Gole et al., 2001; Qiao et al., 2008; Lee et al., 2009; Liu et al., 2009, 
Pissuwan et al., 2010a).  
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Application of AuNPs is dependent on their size and shape such as gold 
nanospheres (AuNSs) and gold nanorods (AuNRs). The use of AuNPs as imaging 
agents could provide a promising future in diagnostic applications. Significant 
diagnostic applications become possible when AuNPs resonances are tuned to the 
near-infrared wavelength. The optical properties of AuNRs in the near infrared (NIR) 
make them a good candidate for diagnostic application. The AuNRs have two surface 
plasmon resonance modes, one longitudinal surface plasmon (LSP) band at 700-1300 
nm and one transverse surface plasmon (TSP) band at 520 nm. On the other hand, 
AuNSs have single surface plasmon resonance mode at 512 nm. The LSP is 
oscillation of the conduction electrons along the length of the AuNRs and TSP is 
oscillation of the conduction electrons along the width of the AuNRs. The main 
advantage of using AuNRs compared to AuNSs in diagnostic application is their 
strong light absorption and scattering (Chang et al., 1997). A few reports proved that 
AuNRs have shown more than 20-fold sensitivity enhancement in biosensing and 20-
times optical absorption efficiencies (Copland et al., 2004; Law et al., 2009).  
 
In diagnostic applications, the conjugation of AuNRs with antibodies shows 
combines unique properties of the nanoparticles with the specific and recognition 
ability of antibodies to antigens. Moreover, conjugation of AuNRs with antibodies 
also improve  the cellular uptake and major intracellular stability (Arruebo et al., 
2009). The functionalized AuNRs with antibodies (IgG) or other biomolecules 
enhance detection at any target cell (Joseph and Yu, 2006; Hutter et al., 2010 ). 
          
4 
 
Besides, Li et al. (2005) reported that high aspect ratio of AuNRs exhibited high 
fluorescence intensity. This unique property of AuNRs finds applications in 
fluorescent probe microarray assays and optical biosensor application for DNA 
analysis (Kuemin et al., 2011).  
 
1.2     Problem statement 
AuNRs have been synthesized by the templating method, photochemical 
(UV-irradiation) and electrochemical synthesis. Martin (1994) fabricated AuNRs 
using a hard-template method (electrochemical deposition in a porous membrane). 
Kim et al. (2002) synthesized AuNRs by UV-irradiation using silver ions to control 
the aspect ratio of AuNRs. However, the aforementioned methods have drawbacks 
such as producing a large quantity of AuNRs with long reaction time, low processing 
yield and difficulty in scaling up. These problems can be overcome by using the 
seed-mediated growth method. The seed mediated growth method is capable of 
producing high yield AuNRs with simple set up at a shorter reaction time (Park et al., 
2009; Chen et al., 2009). Sau and Murphy (2004) obtained high yielding AuNRs 
using seed mediated growth method. Jana et al. (2004) found that seed mediated 
growth method can improve monodispersity of nanoparticles with predetermine size 
by growing large particles from small particles. Gole and Murphy (2004) used ~4 nm 
AuNPs seeds to grow AuNRs. They reported the seed-mediated growth method can 
eliminate the nucleation process and promote growth of AuNRs.  
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Jana et al. (2001) used a stepwise citrate seed mediated method whereby low 
yield AuNRs was formed. Subsequently, Sau and Murphy (2004) modified their 
approach by replacing the citrate with cetyltrimethylammonium bromide (CTAB) 
molecules in the seed formation step. The yield of AuNRs was improved but shorter 
AuNRs were produced. Moreover, some AuNRs produced were in bone-shaped. 
Nikoobakht and El-Sayed (2003) successfully used CTAB capped seed mediated 
growth method to synthesize high yield AuNRs with rod shaped nanoparticles. 
However, their method is difficult in controlling the orientation of the nanorods. 
Meanwhile, Wu et al. (2005) and Bai et al. (2009) used three steps CTAB capped 
seed mediated growth method in the presence of nitric acid (HNO3). Their method 
managed to improve the aspect ratio and growth direction of AuNRs. But, three steps 
growth method is time consuming and requires more chemicals to synthesize the 
AuNRs. In order to improve the aspect ratio and orientation of the produced AuNRs, 
the idea of Wu et al. (2005) and Bai et al. (2009) have been used in this work to 
improve the research work by Nikoobakht and El-Sayed (2003).  
 
In most works, AuNSs were used as detector reagent in 
immunochromatographic (ICG) strip assay for visualization of signals because of 
their stability and easy visual detection attributed to their inherent red color (Nara et 
al., 2010). However, to the authors’ knowledge no work has been carried out on 
using AuNRs as detector reagent in ICG strip assay. In the present work, the ICG 
strip assay has been used to investigate the performance of AuNRs conjugated to 
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antibody (mouse anti-human IgG4). In bio conjugation, the reduced mouse anti-
human IgG4 is more effectively conjugated to the surface positive charge of the 
CTAB-stabilized AuNRs than unreduced mouse anti-human IgG4. This is because 
direct attachment of mouse anti-human IgG4 to AuNRs surface can result in mouse 
anti-human IgG4 inactivity (Jonkheijm et al., 2008). Nevertheless, the bioconjugation 
can be further improved by using covalent attachment between AuNRs with antibody. 
Covalent attachment may increase antibody stability and the available protein 
binding (Arruebo et al., 2009). 
 
1.3      Objectives 
The main objectives of this research are: 
i. To establish the best approach to synthesis gold nanorods (AuNRs). 
ii. To obtain optimum conjugation parameters of AuNRs conjugated antibody. 
iii. To obtain a prototype of gold conjugated antibody for diagnostic  
 applications. 
 
1.4      Overview of thesis  
This dissertation is organized in five chapters. Chapter 1 contains 
introduction and the objectives of this research. In Chapter 2, literature review which 
contains definition and background studies of AuNPs, brief history of AuNPs, optical 
properties of AuNPs and methods to synthesize AuNPs are explained. Also, literature 
review related to antibodies, coupling strategies for bioconjugation and applications 
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of AuNPs are discussed. In Chapter 3, experimental procedure, various parameters 
studied and characterizations techniques are explained. Chapter 4, the outcomes from 
experiments such as effect of parameters on the growth of AuNRs and effect of 
AuNRs conjugated to antibodies in diagnostic application are presented. Finally, the 
conclusion and recommendation for future work are described in Chapter 5.  
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1     Introduction 
In this chapter, literature review on background studies, properties, and brief 
history of gold nanoparticles (AuNPs) are explained. This is followed by a 
comparison of the various methods used to synthesize AuNPs. Moreover, diagnostic 
application of AuNPs conjugated with antibody is also discussed.  
 
2.2     Brief history of gold nanoparticles (AuNPs) 
AuNPs is one of the most ancient subjects in science. In an antiquity, AuNPs 
was used for aesthetic and curative purposes. AuNPs have been used to make ruby 
glass and for coloring ceramics since Glauber’s found it in the 17th century of 
“Purple of Cassius” (Daniel and Astruc, 2004). Around the 1600, Paracelus described 
the experiment of “aurum potable, oleum auri; Quinta essential auri” with the 
reduction of auric chloride (AuCl3) and alcoholic extract of plant (Weiser, 1933). But 
in 18th century, as indicated in a French dictionary, dated 1769, under the heading 
“or potable”, it was mentioned that “drinkable Au contained Au in its elementary 
form but under extreme sub-division suspended in a liquid” (Chymie, 1769). During 
Middle Ages, colloidal Au was used to cure various diseases, such as heart and 
venereal issues, tumors, and for diagnoses syphilis (Brown and Smith, 1980). 
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                 In 1857, English scientist Faraday reported the formation of deep-red 
solution of AuNPs by reduction of an aqueous solution of chloroaurate (AuCl4
-
) 
using phosphorus in CS2 (a two-phase system). The dried colloidal solution was 
prepared and  the optical properties of thin films were investigated (Faraday, 1857). 
Faraday’s samples of “AuNPs” are still on display at the Royal Institute in London 
(Peter and John, 2007).The term “colloidal” (derived from the Greek word for glue 
kola (Hayat, 1989), which became the French word collel was coined shortly 
thereafter by Graham, in 1861. Since 1885, colloidal Au has been used for its healing 
capabilities for the heart and to improve blood circulation. Besides, colloidal gold 
has been used to heal arthritis since 1927. 
 
In the 20th century, AuNPs have received wide attention because of its 
importance in the industrial process and biochemistry. AuNPs are expected to be key 
materials and building blocks as well as play an important role in biomedicine field 
in the near future (Daniel, 2004; Doty et al., 2004; Cushing et al., 2004; Love et al., 
2005; Rosi and Mirkin, 2005). 
 
2.3      Definition and background studies of gold nanoparticles (AuNPs) 
Gold nanoparticles (AuNPs) are a cluster of gold atoms with size ranging 
from 1-100 nanometers. AuNPs have gained increasing importance in 
nanotechnology due to their special features, such as tunable size and shapes of 
AuNPs, strong absorption and scattering properties, easy surface functionalization, 
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biological compatibility,  simple set up for synthesizing AuNPs and high stability to 
oxidation (Sperling et al., 2008; Grzelczak et al., 2008; Love et al., 2005; Kim et al., 
2004). AuNPs can be synthesized into various shapes such as spheres, rods, wires, 
ribbons, cubic, triangle and plate. Moreover, the size can be tuned to range between 2 
to 500 nm. 
 
The synthesis of colloidal AuNPs via chemical method from a homogeneous 
solution involves three consecutive stages: nucleation, growth and coagulation. In 
nucleation stage, nuclei are created upon which growth can occur. During the growth 
stage, more gold (Au) ions deposit on the existing nuclei and followed by 
agglomeration of many Au ions onto the growing AuNPs. The latter can occur via 
the following mechanisms: (i) growth consuming molecular precursors from 
surrounding solution; (ii) Ostwald ripening or coarsening when larger particles grow 
at the expense of dissolving smaller ones (Claudi et al., 2002; Talapin et al., 2001). 
 
AuNPs have received much attention during the past several decades as they 
play an important role in the various areas of materials sciences. The AuNPs 
especially gold nanospheres (AuNSs) and gold nanorods (AuNRs) have been widely 
used in biomedical applications. AuNSs have been produced via numerous 
techniques including ligand-exchange, phosphine-stabilized, two-phase transfer 
method, direct reduction method, and seed mediated growth (Luo et al., 2005; Waere 
et al., 2000; Shem et al., 2009; Brust et al., 1994; Turkevitch, 1951; Huang et al., 
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2007; Patungwasa and Hodk, 2008). Meanwhile, for the synthesis of AuNRs, a 
number of techniques have been reported such as seed mediated growth, 
photochemistry and electrochemical method (Nikoobakht and El-Sayed, 2001; 
Nikoobakht and El-Sayed, 2003; Jana et al., 2001b; Gao and Murphy, 2003; Gao and 
Murphy, 2004; Niu et al., 2007; Kim et al., 2002; Chang et al., 1998). Table 2.1 
shows the comparisons of various methods to synthesize AuNPs. According to Luo 
et al. (2005), the ligand exchange method has several limitations in regard to the 
synthesis of AuNSs such as difficulty in controlling the shell thickness, the number 
of AuNPs inside each micelle, and the location of nanoparticles. In order to obtain 
shell nanostructure with one AuNSs per micelle, empty micelles must be separated 
from the product. Waere et al. (2000) used the phosphine-stabilized method to 
produce AuNSs. This method requires rigorous anaerobic condition and diborane gas 
as a reducing agent. Diborane gas is a flammable and toxic gas, which is dangerous 
to the environment and health. Monolayer protected AuNSs synthesized by a two-
phase transfer method contain a significant amount of tetraoctylammonium bromide 
(TOABr) (Water et al., 2003). The quaternary ammonium salt of TOABr was used as 
the phase transfer reagent and as a persistently retained impurity. However, the team 
is still unclear on the method to confirm the presence of TOABr as an impurity in the 
nanoparticle samples resulting from the two-phase preparation technique. 
  
Patungwasa and Hodak (2008) have used direct reduction method to produce 
AuNSs. The size of AuNSs can be easily controlled to form a stable colloidal 
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suspension. In this approach, Au salt must be heated before citrate addition. Citrate 
serves as a capping agent because it cannot reduce Au salt at room temperature. 
However, direct citrate method produced nanospheres with a broad range of size and 
agglomeration can easily occur. To solve the aforementioned disadvantages, Jana et 
al. (2001b)  proposed seed mediated method  to produce monodisperse nanospheres. 
In seed mediated method, smaller AuNSs act as nucleation sites for the growth of 
larger AuNPs. This method involves two steps preparation of seed solution and 
growth solution. With this approach, either a one step, or step by step growth can be 
used to synthesize larger AuNSs. Besides, the AuNRs can also be produced by using 
seed mediated growth method. The CTAB plays an important role in this approach 
because CTAB is uniquely suited to produce rod-shape nanoparticles. 
 
Kim et al. (2002) developed a method for the synthesis of AuNRs by 
photochemically reducing Au ions in the presence of CTAB and AgNO3. In that 
method, an aqueous solution of CTAB, HAuC14.3H2O, and AgNO3 was irradiated 
with UV light. The authors found that the aspect ratio of AuNRs is directly 
proportional with the amount of AgNO3. In 1997, Yu et al. reported the 
electrochemical method for the aqueous synthesis of AuNRs. In this method metallic 
Au plate was used as an anode in the electrochemical cell. Meanwhile, the 
electrolytic solution contains a cationic surfactant, hexadecyltrimethylammonium 
bromide (C16TAB), and a small amount of tetradodecylammonium bromide 
(TC12AB). There are two main functions of C16TAB in this method,
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first as the supporting electrolyte and the second as a stabilizer for nanoparticles to prevent their further growth. The reduction of Au 
ions from aqueous causes nucleation of AuNRs on the electrode plate. The authors also reported that the presence of silver in the 
electrolytic solution affect the aspect ratio of AuNRs. 
 
Table 2.1: Methods to synthesize AuNPs. 
      Method Description of method Advantages Drawbacks Refs. 
(a) Ligand exchange 
method 
Displacement of one 
ligand for another on 
AuNSs surface 
  
1. Produce different     
ligands    shells,  and     
AuNPs cluster  size   
can be preserved. 
2. Physical properties of    
ligand shell can be   
tuned. 
 
1. The shell thickness, the 
number of AuNPs inside 
each micelle, and the 
location of nanoparticles 
are difficult to control. 
2. Empty micelles  must be 
separated from the 
product to obtain shell 
nanostructure with one 
AuNSs per micelle 
 
(Luo et al., 2005; 
Young et al., 2008; 
Tour et al., 1995; 
Brust et al., 1995) 
(b) Phosphine-
stabilized 
Using diborane gas to 
reduce gold chloride 
(HAuCl3) to form 
AuCl(PPh3) under 
warm benzene 
1.Phosphine-stablized   
   particles can act as the  
   starting materials for   
   production of      
   nanoparticles    
   functionalized  
   by other ligands such   
   as thiols, amines, and   
   other phosphines. 
1. Requires rigorous 
anaerobic condition and 
diborane gas as a 
reducing agent. 
(Shem et al., 2009; 
Feldheim et al., 
1996; Waere et al., 
2000) 
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2. Phosphine-stabilized  
nanoparticles are   
precursors to other   
functionalized  
nanoparticle building  
blocks possesses well-  
defined metallic core. 
 
(c) Two-phase 
transfer 
 
 
 
 
 
 
 
 
 
Use stabilizing agent, 
reducing agent, and 
tetraoctylammonium 
bromide (TOABr) to 
synthesize AuNSs. 
Reducing agent and 
TOABr are phase 
transfer catalyst. 
1. Stable and 
monodisperse 
nanoparticles can be 
synthesized.  
 
1. The tetraoctylammonim 
bromide (TOABr) is 
always retained even after 
repeated precipitation and 
washing with ethanol or 
acetone. 
2. Phase-transfer catalyst is 
needed during synthesis 
of AuNPs. 
(Rowe et al., 2004; 
Brust et al., 1994; 
Waters et al., 2003) 
(d) Direct reduction 
method 
The precursor salts, 
reducing agents and 
stabilizer are used to 
synthesis AuNSs. 
 
1. Use less energy. 
2. Size of AuNSs can be 
controlled. 
3. Easily form colloidal 
suspension with high 
stability. 
4. Straight forward to 
produce nanoparticles. 
 
1. Low yield.  
2. Broad size distribution 
range.   
3. Agglomeration easily 
occurs. 
(Turkevitch,1951; 
Zhu et al., 2003; 
Liu and Philippe, 
2004; Huang et al., 
2007; Patungwasa 
and Hodak, 2008)  
 
 
 
 
(e) Seed mediated 
growth 
Smaller AuNSs act as 
nucleation sites for 
growth of larger 
1. Eliminate nucleation 
step. 
2. Promote growth. 
1. 1-10 nm nanoparticles are 
difficult to synthesis   
2. Large size distribution 
(Jana et al., 2001b; 
Niu et al., 2007; 
Brown and 
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AuNSs. This method 
can also be used to 
synthesis AuNRs. 
3. Improved 
monodispersity of 
nanoparticles. 
4. Predetermined size of 
larger particles can be 
grown from small 
particles. 
range of AuNPs is 
produced. 
  
Michael, 1998; 
Brown et al., 1999)  
(f) Photo- 
chemistry 
Irradiation of an 
aqueous solution of 
gold ions to form 
AuNRs. 
 
 
1. Promising for 
synthesizing uniform 
nanorods. 
2. Reduction of metal 
ions can be controlled 
without using excess 
reducing agent. 
 
1. Long reaction time (more 
than 30 hours) is required. 
(Kim et al., 2002; 
Niidome et al. 
2003; Dong et al., 
2004; Liu and 
Scaiano, 2009) 
(g) Electro- 
chemical 
Reduction of Au ions 
from aqueous causes 
nucleation of AuNRs on 
the electrode surface. 
This method has been 
used to form AuNRs. 
1. Holding a good 
controllability in the 
particles’ dimensions. 
 
1. Low yield of AuNRs. (Chang et al., 
1998; Yu et al., 
1997; Alqudami et 
al., 2008) 
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AuNPs have been widely used in diagnostic application due to its high 
stability in biological environment, unique optical properties, large surface area, 
availability of versatile chemistry for functionalizing AuNPs surface, and excellent 
biocompatibility  (Li and Rothberg, 2004; Davidson and Huang, 2003; Gupta and 
Velev, 2009; Yang et al., 2009). AuNPs are stable in biological environment, thus 
metallic gold surface can be attached to biomolecules such as antibody, DNA etc 
with the presence of gold-sulphur bond or electrostatic attraction. Moreover, AuNPs 
have surface plasmon polaritons and surface plasmon resonances, which are in the 
visible and near-infrared spectral regions (Hayat, 1989; Schmid, 1992). These 
properties make AuNPs are sought after in optical imaging and detection applications. 
Also, gold is a heavy element and has a high atomic number that can be detected by 
electron microscopes or by X-rays (Gillaspy, 2001). 
 
2.4  Optical properties: surface plasmon resonance (SPR) in gold    
 nanoparticles (AuNPs) 
Surface plasmon resonance (SPR) is a quantum optical-electrical 
phenomenon due to the interaction of incoming light with a metal surface. When the 
incoming light is larger than the diameter of nanoparticles (d << λ), the 
electromagnetic (EM) field across the entire sphere nanoparticle is essentially 
uniform as shown in Figure 2.1 (Hutter and Fendler, 2004). The free or weakly 
bound conduction electrons in the noble metal respond collectively when the EM 
field oscillates back and forth (in the direction of E-field polarization). The resonance 
is due to the incoming light frequency equal to the intrinsic electron oscillation 
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frequency. This condition causes the incoming light is completely absorbed. The 
resonance wavelength is at the position where the maximum light is absorp. 
 
                                              
     
 
 
 
Figure 2.1: SPR occurs when the interaction between electromagnetic (EM) field 
with the electrons in the conduction band for a metal sphere 
(Hutter and Fendler, 2004). 
 
AuNRs differ from spheres since they have a particular aspect ratio in which 
the material is elongated along a single dimension, keeping the other two dimensions 
approximately equal. It is essential to limit the growth direction to a single axis in 
order to synthesize nanorods. AuNRs have two peaks in their absorbance spectra that 
correspond to plasmon resonances: one at approximately 520 nm from plasmon 
oscillation in the shorter transverse direction and a second at longer wavelength 
(typically between 700 nm and 1300 nm) from longitudinal oscillation (Burda et al., 
2005; Brown et al., 1999; Link and El-Sayed, 2003). The transverse SPR is due to 
electronic oscillation across the width of rod shape. Meanwhile, the longitudinal SPR 
is due to electronic oscillation across the length of the rod shape. By varying the 
aspect ratio (length divided by width) of rod shape, the position of the longer 
Metal sphere 
Metal sphere 
Incoming Light 
(E-field) 
e- cloud 
e- cloud 
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wavelength plasmon peak can be tuned out to the near-infrared region, where 
absorbance by cells and tissue is minimal (Weissleder, 2001). Besides, AuNRs has 
potential for selective thermal destruction of cancerous tissues (Liao and Hafner, 
2005). Figure 2.2 shows adsorption spectra of AuNRs of different aspect ratios. The 
SPR peaks shift to the right side by increasing the aspect ratio of AuNRs. The color 
solution of AuNRs are tunable as a function of longitudinal SPR. For short AuNRs 
with the longitudinal SPR lower than 700 nm, the AuNRs appear in blue color. The 
deep red color of solution does not change significantly when the longitudinal SPR is 
between 700 nm and 800 nm. The solution colour changes to pink with the 
longitudinal SPR larger than 800 nm. 
 
 
Figure 2.2: Optical absorption spectra of AuNRs with different aspect ratios:  
(a) 2.4; (b) 3.0; (c) 3.9; (d) 4.8; (e) 5.6 (Huang et al., 2009). 
 
The cause of the color dependence is based on the conductive surface's 
electron vibrational states, called surface plasmon modes. The reflection properties 
are a dramatic function of the AuNSs diameter. In AuNSs synthesis, the size 
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influence the colour of the gold colloidal suspension as listed in Table 2.2. The 
increase of the size of AuNSs causes the color to change from pale blue to violet. 
This is because increasing the AuNSs size will result in the wavelength of SPR 
related absorption shifting to longer wavelengths (redder).  
 
Table 2.2: Size and shape determine the physical colour of AuNPs  
(Turrkevitch, 1951; Wilenzick et al., 1967; Frens, 1973). 
Shape Size in nm Colour 
Spherical < 3 Pale blue 
 12 Pink 
 16 Orange 
 20-40 Red 
 70 Dark magenta 
 100-150 Violet 
 
 
The SPR peaks of AuNRs can be tuned as a function of aspect ratio. Ling et 
al. (2009) produced AuNRs with aspect ratio varying from 1.7 to 4.0, while Park 
(2006) synthesized AuNRs with further increase in the aspect ratio to 7.4. Figure 2.3 
shows the photograph of the AuNRs with aspect ratio varying from 1.7 to 7.4. It can 
be concluded that the color change could be only observed by human eyes for the 
AuNRs with aspect ratios below than 3.5. For the AuNRs beyond the aspect ratio of 
around 3.5, color of the solution is basically the same. That means the color of 
AuNRs dispersion does not change with further increase in aspect ratio beyond 3.5.  
 
In addition, Park, 2006 found that the color in a visible region is more 
sensitive to the amount of spherical particles included as byproduct since SPR peak 
of sphere positions between 500 to 550nm. Figure 2.4 shows the simulated color of 
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AuNRs with aspect ratio of 5.  It can be observed that the color changes from purple 
to brown as the amount of byproduct decreases from 50 % to 0 %. 
 
  
Figure 2.3: Photographs of five AuNRs solution. Aspect ratios are  
(a) 1.7, (b) 2.3, (c) 2.7, (d) 3.5 and (e) 4.0 (from the left to right) 
 (Ling et al., 2009; Park, 2006). 
 
 
 
 
 
Figure 2.4: The color of AuNRs solution of having different amount of spheres as 
byproduct. (a) 50%, (b) 30%, (c) 10%, and (d) 0% (Park, 2006). 
 
The free conduction electrons in AuNPs oscillate at specific wavelengths 
which relate to the nanoparticle’s size, and produce an absorbance peak. The SPR 
absorption peaks of AuNPs can be tuned as a function of particle size, shape, and 
aggregate morphology (Link et al., 1999; Link et al., 2004; Kelly et al., 2002; 
Caruso and Antonietti, 2001; Hutter and Fendler, 2004). The size or shape of the 
(a) (b) (c) (d) 
(a) (b) (d) (c) (e) 
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AuNPs alters the electric field density on the surface. This is because the oscillation 
frequencies of the electrons are changed. Therefore, as the size of the particle 
increases, the localized surface plasmon dipolar resonance tends to broaden and shift 
to longer wavelengths. Table 2.3 and Figure 2.5 show the different plasmon modes 
according to the shape of AuNPs. The spheres and hollow spheres shape only have 
one plasmon mode, which is called transverse surface plasmon. Meanwhile, rod 
shape has two plasmon mode called transverse surface plasmon (represent width of 
AuNPs) and longitudinal surface plasmon (represent length of AuNPs). The 
aggregates of AuNPs have more complex optical absorption with many bands over a 
broad spectral region. 
 
Table 2.3: Plasmon mode of the AuNPs with varying shapes. 
 
Shape  Number of 
plasmon mode 
Reason for number of plasmon 
mode 
Refs. 
Spheres 1 Completely symmetrical about 
at perspective 
 
(Encina and 
Coronado, 2010a; 
Encina and 
Coronado, 2010b) 
            Rods 2 Rod shapes have width and 
length dimensions  
 
(Zuloaga et al., 
2010; Grzelczak et 
al., 2007) 
      Hollow      
      spheres 
1  
(narrow 
resonance) 
Highly uniform shell structure 
 
(Olson et al., 2008; 
Wheeler et al., 2010) 
     Aggregates Multiple Lots of nanoparticles 
aggregated, many 
nondegenerate modes arise.  
 
(Schwartzberg et al., 
2007) 
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Figure 2.5: Schematic illustration of plasmon resonance of solid metal,  
(a) gold nanoparticle, (b) nanorod, (c) hollow gold nanospheres (HGN), and  
(d) aggregate gold nanoparticles (Schwartzberg and Zhang, 2008). 
 
2.5      Synthesis methods to produce gold nanoparticles (AuNPs) 
There are various methods to synthesize AuNPs including AuNSs and 
AuNRs. Among them is wet chemical synthesis method that is cost-effective and has 
potential for large-scale production of AuNPs. There are two approaches in the 
synthesis of AuNPs using wet chemical synthesis methods: direct reduction or seed 
mediated growth method. In direct reduction method, the AuNPs are formed by 
using reducing agent. Meanwhile, in the seed mediated growth method, firstly small 
AuNPs are prepared and then used as seeds (nucleation sites) for the preparation of 
desired size or shape of AuNPs. These seeds will then grow into larger sizes during 
the growth stage. 
 
One resonance 
Multiple resonances One resonance 
(a) (b) 
(d) 
(c) 
Transverse 
Longitudinal 
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2.5.1   Gold nanospheres (AuNSs) 
           Gold nanospheres (AuNSs) are small spheres which can be in any size from 
only a few nanometers to several hundred nanospheres (Loo et al., 2005). There are 
two main methods to produce AuNSs by wet chemical synthesis method: direct 
reduction method and seed mediated growth method. The direct reduction method 
can be categorized in two ways, (i) Fren method, and (ii) Brust-Schiffrin method. 
Frens method utilizes citrate reduction of gold salt; AuNSs in the sizes ranging from 
12 to 20 nm (relatively size distribution ~10-16 %) can be produced. However, the 
product has large particles size distribution (polydisperse), tend to aggregate and 
yields unsatisfactory results (Jana et al., 2001b; Brown et al., 1999). While in the 
Brust method, smaller AuNSs (1-5 nm) were synthesized by using sodium 
borohydride (strong reducing agent) as a reductant. 
 
Direct reduction method is a simple route in synthesizing high quality AuNSs. 
The advantages of direct reduction method lies in its capability to tune particle size, 
form a stable colloidal suspension and employ less energy (Turrkevitch, 1951; Zhu et 
al., 2003). The direct reduction method utilizes three main items; a precursor, a 
reducing agent and a stabilizer. Different chemicals could be used as reducing agents 
to produce AuNSs. These reagents could be inorganic, organic or natural reducing 
agent for instance sodium/potassium borohydrate, hydrazine, or organic such as 
sodium citrate (sometimes known as trisodium citrate), ascorbic acid, soy bean 
(Chandrasekharan et al., 2000; Shukla et al., 2008; Tsai et al., 2004; Buining et al., 
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1997; Jana and Murphy, 2001; Kakkassery et al., 2004). Table 2.4 summarizes the 
reducing agents and stabilizers that have been used to synthesize AuNSs.  When 
hydrazine was used as a reducing agent in synthesizing AuNSs, the range of particles 
size were larger (10-60 nm) compared to when sodium citrate was used (10-22 nm). 
In addition, the particles size range was 3.5-4.5 nm obtained when trisodium citrate 
mixed with NaBH4, but the particles size range (17-21 nm) larger when only 
trisodium citrate was used as reducing agent. The examples of stabilizer are sodium 
3-mercaptopropionate (MPA-Na), mercaptosuccinic acid (MSA) etc. Yonezawa and 
Kunitake (1999) reported that simultaneous addition of sodium 3-
mercaptopropionate (MPA-Na) and trisodium citrate can increase the stability of 
AuNPs. The authors also examined the reduction by a strong reducing agent 
(NaBH4), but it produced non-uniform MPA-stabilized AuNPs between the ranges of 
5 and 20 nm. Zhu et al. (2003) reported that MSA is a stronger capping agent than 
trisodiun citrate. MSA facilitates more uniform and robust capping role in surface-
assisted reduction for AuNPs growth. 
 
Table 2.4: Reducing agents in synthesizing AuNSs. 
Reducing agent Stabilizer Particle size (nm) Refs. 
Sodium citrate - 10 - 22 nm 
 
(Turrkevitch, 1951; 
Jana et al., 2001a; 
Kakkassery et al., 
2004) 
Trisodium citrate Sodium 3-
mercaptopropionate 
(MPA-Na) 
2.3 - 10.0 nm (Yonezawa and 
Kunitake, 1999) 
Trisodium citrate 
and NaBH4 
- 3.5 - 4.5 nm 
 
(Jana et al., 2001c) 
Trisodium citrate - 17 - 21 nm (Zhu et al., 2003;  
Ding et al., 2006) 
Trisodium citrate Na2(MSA) 20.0 nm (Zhu et al., 2003) 
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Trisodium citrate Thionine 18.0 nm (Ding et al., 2006) 
NaBH4 
 
(γ-mercaptopropyl) 
Trimethoxysilane 
(MPS) 
 
1.0 - 5.0 nm 
 
(Buining et al., 
1997) 
NaBH4 Thiol 2.9 - 6.0 nm (Johnson et al., 
1998) 
NaBH4 Mercaptosuccinic 
acid (MSA) 
1.02 nm (Chen and Kimura, 
1999) 
NaBH4 - 2.0 - 2.6 nm (Maxwell et al., 
2002) 
NaBH4 Thiol or disulfide 1.5 - 3.5 nm (Maitra & 
Shreedhar, 2008) 
Ascorbic acid - 5.0 - 50.0 nm (Wagner and 
Kohler, 2005; 
Vemula et al., 
2006) 
Sodium citrate and 
tannic acid 
- 3 - 17 nm (Tsai et al., 2004) 
Gallic acid - 10 - 29 nm (Wang et al., 2007) 
Hydrazine - 10 - 60 nm (Kawasaki et al., 
2007) 
L-tryptophane Polyethylene glycol 
(PEG) 
      10 - 25 nm (Akbarzadeh et al., 
2009) 
 
Among the listed reducing agent, citrate reduction has been widely used. In 
citrate reduction method, the gold atoms are formed in four reactions (Kumar et al., 
2007). In reaction (2.1), citrate is initiated with oxidation process and yields 
dicarboxy acetone. Reaction (2.2) involves reduction of auric salt to form aurous salt. 
The electrons donated by citrate to gold ions to form gold atoms (Au
0
). The aurous 
salt is regenerated in reaction (2.3), and disproportionation to form gold atoms. The 
pH of the final solution becomes lower because other ions presence in the medium 
makes the solution acidic in nature. Reaction (2.4) is the overall stoichiometry of 
reduction reaction. The reduction of a gold salt (HAuCl4) is to form gold metal. In 
this reaction, gold can exist in three oxidation states: Au
3+
, Au
+
 and Au
0
. Reactions 
(2.5) and (2.6) show the oxidation energy during the reaction. 
